Cargando…
Development of a Biomarker Panel to Distinguish Risk of Progressive Chronic Kidney Disease
Chronic kidney disease (CKD) patients typically progress to kidney failure, but the rate of progression differs per patient or may not occur at all. Current CKD screening methods are sub-optimal at predicting progressive kidney function decline. This investigation develops a model for predicting pro...
Autores principales: | Owens, Evan, Tan, Ken-Soon, Ellis, Robert, Del Vecchio, Sharon, Humphries, Tyrone, Lennan, Erica, Vesey, David, Healy, Helen, Hoy, Wendy, Gobe, Glenda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764886/ https://www.ncbi.nlm.nih.gov/pubmed/33327377 http://dx.doi.org/10.3390/biomedicines8120606 |
Ejemplares similares
-
Kidney failure, CKD progression and mortality after nephrectomy
por: Ellis, Robert J., et al.
Publicado: (2022) -
PAR2 Activation on Human Kidney Tubular Epithelial Cells Induces Tissue Factor Synthesis, That Enhances Blood Clotting
por: Iyer, Abishek, et al.
Publicado: (2021) -
Promoting Plant-Based Therapies for Chronic Kidney Disease
por: Khan, Muhammad Ali, et al.
Publicado: (2022) -
PAR2-Induced Tissue Factor Synthesis by Primary Cultures of Human Kidney Tubular Epithelial Cells Is Modified by Glucose Availability
por: Humphries, Tyrone L. R., et al.
Publicado: (2021) -
Two-dimensional correlated spectroscopy distinguishes clear cell renal cell carcinoma from other kidney neoplasms and non-cancer kidney
por: Del Vecchio, Sharon J., et al.
Publicado: (2022)